The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M protein in inducing IL-6 and C3 secretion from human mesangial cells: Implications for IgA nephropathy

Journal of Immunology

Volumn 193, Issue 1, 2014, Pages 317-326

  Schmitt, Roland ^a   Ståhl, Anne Lie ^a   Olin, Anders I ^a   Kristoffersson, Ann Charlotte ^a   Rebetz, Johan ^a   Novak, Jan ^b   Lindahl, Gunnar ^c   Karpman, Diana ^a  

^a LUND UNIVERSITY   (Sweden)

^b University of Alabama at Birmingham   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; GALACTOSE DEFICIENT IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A1; INTERLEUKIN 6; M PROTEIN; STREPTOCOCCAL IMMUNOGLOBULIN A1 BINDING M4 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MESANGIUM CELL; MIDDLE AGED; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; STREPTOCOCCUS GROUP A; SURFACE PLASMON RESONANCE;

ADOLESCENT; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; COMPLEMENT C3; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-6; MALE; MESANGIAL CELLS; MIDDLE AGED; STREPTOCOCCUS;

EID: 84903575263     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302249     Document Type: Article

References (67)

1. Donadio, J. V., and J. P. Grande. 2002. IgA nephropathy. N. Engl. J. Med. 347: 738-748.
2. Moldoveanu, Z., R. J. Wyatt, J. Y. Lee, M. Tomana, B. A. Julian, J. Mestecky, W. Q. Huang, S. R. Anreddy, S. Hall, M. C. Hastings, et al. 2007. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 71: 1148-1154.
3. Novak, J., B. A. Julian, J. Mestecky, and M. B. Renfrow. 2012. Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin. Immunopathol. 34: 365-382.
4. Woof, J. M., and M. A. Kerr. 2006. The function of immunoglobulin A in immunity. J. Pathol. 208: 270-282.
5. Mestecky, J., M. Raska, B. A. Julian, A. G. Gharavi, M. B. Renfrow, Z. Moldoveanu, L. Novak, K. Matousovic, and J. Novak. 2013. IgA nephropathy: molecular mechanisms of the disease. Annu. Rev. Pathol. 8: 217-240.
6. Tam, K. Y., J. C. Leung, L. Y. Chan, M. F. Lam, S. C. Tang, and K. N. Lai. 2009. Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro. Kidney Int. 75: 1330-1339.
7. Monteiro, R. C., I. C. Moura, P. Launay, T. Tsuge, E. Haddad, M. Benhamou, M. D. Cooper, and M. Arcos-Fajardo. 2002. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol. Med. 8: 464-468.
8. Chen, A., W. P. Chen, L. F. Sheu, and C. Y. Lin. 1994. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J. Pathol. 173: 119-126.
9. Kiryluk, K., Z. Moldoveanu, J. T. Sanders, T. M. Eison, H. Suzuki, B. A. Julian, J. Novak, A. G. Gharavi, and R. J. Wyatt. 2011. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 80: 79-87.
10. Feehally, J. 1988. Immune mechanisms in glomerular IgA deposition. Nephrol. Dial. Transplant. 3: 361-378.
11. Gharavi, A. G., Z. Moldoveanu, R. J. Wyatt, C. V. Barker, S. Y. Woodford, R. P. Lifton, J. Mestecky, J. Novak, and B. A. Julian. 2008. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J. Am. Soc. Nephrol. 19: 1008-1014.
12. Waldherr, R., M. Rambausek, W. D. Duncker, and E. Ritz. 1989. Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol. Dial. Transplant. 4: 943-946.
13. Rekola, S., A. Bergstrand, H. Bucht, and A. Lindberg. 1985. Are betahaemolytic streptococci involved in the pathogenesis of mesangial IgA-nephropathy? Proc. Eur. Dial. Transplant Assoc. Eur. Ren. Assoc. 21: 698-702.
14. Kukuminato, Y., M. Hamamoto, and A. Kataura. 1993. Role of serum antibodies to streptococci in patients with IgA nephropathy. Acta Otolaryngol. Suppl. 508: 6-10.
15. Nakatsuka, K. 1993. Serum anti-streptococcal IgA, IgG and IgM antibodies in IgA-associated diseases. Acta Paediatr. Jpn. 35: 118-123.
16. Schmitt, R., F. Carlsson, M. Mörgelin, R. Tati, G. Lindahl, and D. Karpman. 2010. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schönlein purpura. Am. J. Pathol. 176: 608-618.
17. Suzuki, S., Y. Nakatomi, H. Sato, H. Tsukada, and M. Arakawa. 1994. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 343: 12-16.
18. Koyama, A., S. Sharmin, H. Sakurai, Y. Shimizu, K. Hirayama, J. Usui, M. Nagata, K. Yoh, K. Yamagata, K. Muro, et al. 2004. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 66: 121-132.
19. Takahashi, A., Y. Kawasaki, K. Yoshida, K. Mochizuki, M. Isome, K. Honzumi, R. Nozawa, S. Suzuki, M. Hosoya, J. Suzuki, and H. Suzuki. 2005. Detection of enteroviruses in renal biopsies from patients with immunoglobulin A nephropathy. Pediatr. Nephrol. 20: 1578-1582.
20. Frithz, E., L. O. Hedén, and G. Lindahl. 1989. Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes. Mol. Microbiol. 3: 1111-1119.
21. Pleass, R. J., T. Areschoug, G. Lindahl, and J. M. Woof. 2001. Streptococcal IgA-binding proteins bind in the Ca2-Ca3 interdomain region and inhibit binding of IgA to human CD89. J. Biol. Chem. 276: 8197-8204.
22. Schmitt, R., G. Lindahl, and D. Karpman. 2010. Antibody response to IgAbinding streptococcal M proteins in children with IgA nephropathy. Nephrol. Dial. Transplant. 25: 3434-3436.
23. Lim, C. S., S. Zheng, Y. S. Kim, C. Ahn, J. S. Han, S. Kim, J. S. Lee, D.W. Chae, J. R. Koo, R.W. Chun, and J.W. Noh. 2001. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol. Dial. Transplant. 16: 269-275.
24. Horii, Y., A. Muraguchi, M. Iwano, T. Matsuda, T. Hirayama, H. Yamada, Y. Fujii, K. Dohi, H. Ishikawa, Y. Ohmoto, et al. 1989. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J. Immunol. 143: 3949-3955.
25. Horii, Y., M. Iwano, E. Hirata, M. Shiiki, Y. Fujii, K. Dohi, and H. Ishikawa. 1993. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int. Suppl. 39: S71-S75.
26. Novak, J., L. Raskova Kafkova, H. Suzuki, M. Tomana, K. Matousovic, R. Brown, S. Hall, J. T. Sanders, T. M. Eison, Z. Moldoveanu, et al. 2011. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Nephrol. Dial. Transplant. 26: 3451-3457.
27. Kiryluk, K., J. Novak, and A. G. Gharavi. 2013. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu. Rev. Med. 64: 339-356.
28. Wyatt, R. J., and B. A. Julian. 1988. Activation of complement in IgA nephropathy. Am. J. Kidney Dis. 12: 437-442.
29. Roos, A., M. P. Rastaldi, N. Calvaresi, B. D. Oortwijn, N. Schlagwein, D. J. van Gijlswijk-Janssen, G. L. Stahl, M. Matsushita, T. Fujita, C. van Kooten, and M. R. Daha. 2006. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J. Am. Soc. Nephrol. 17: 1724-1734.
30. van den Dobbelsteen, M. E., V. Verhasselt, J. G. Kaashoek, J. J. Timmerman, W. E. Schroeijers, C. L. Verweij, F. J. van der Woude, L. A. van Es, and M. R. Daha. 1994. Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. Clin. Exp. Immunol. 95: 173-180.
31. Timmerman, J. J., D. J. Van Gijlswijk-Janssen, S. W. Van Der Kooij, L. A. Van Es, and M. R. Daha. 1997. Antigen-antibody complexes enhance the production of complement component C3 by human mesangial cells. J. Am. Soc. Nephrol. 8: 1257-1265.
32. Miyazaki, M., K. Abe, T. Koji, A. Furusu, Y. Ozono, T. Harada, P. K. Nakane, M. Yagame, M. Endoh, Y. Nomoto, and H. Sakai. 1996. Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J. Am. Soc. Nephrol. 7: 2428-2433.
33. Johnsson, E., G. Andersson, G. Lindahl, and L. O. Hedén. 1994. Identification of the IgA-binding region in streptococcal protein Arp. J. Immunol. 153: 3557-3564.
34. Morfeldt, E., K. Berggård, J. Persson, T. Drakenberg, E. Johnsson, E. Lindahl, S. Linse, and G. Lindahl. 2001. Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation. J. Immunol. 167: 3870-3877.
35. Carlsson, F., K. Berggård, M. Stålhammar-Carlemalm, and G. Lindahl. 2003. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J. Exp. Med. 198: 1057-1068.
36. Stålhammar-Carlemalm, M., J. Waldemarsson, E. Johnsson, T. Areschoug, and G. Lindahl. 2007. Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine. Cell Host Microbe 2: 427-434.
37. Suzuki, H., R. Fan, Z. Zhang, R. Brown, S. Hall, B. A. Julian, W. W. Chatham, Y. Suzuki, R. J.Wyatt, Z. Moldoveanu, et al. 2009. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest. 119: 1668-1677.
38. Novak, J., M. Tomana, M. Kilian, L. Coward, R. Kulhavy, S. Barnes, and J. Mestecky. 2000. Heterogeneity of O-glycosylation in the hinge region of human IgA1. Mol. Immunol. 37: 1047-1056.
39. Takahashi, K., S. B. Wall, H. Suzuki, A. D. Smith, IV, S. Hall, K. Poulsen, M. Kilian, J. A. Mobley, B. A. Julian, J. Mestecky, et al. 2010. Clustered Oglycans of IgA1: defining macro-and microheterogeneity by use of electron capture/transfer dissociation. Mol. Cell. Proteomics 9: 2545-2557.
40. Franc, V., P. Rehulka, M. Raus, J. Stulík, J. Novak, M. B. Renfrow, and M. Sebela. 2013. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing. J. Proteomics 92: 299-312.
41. Allen, A. C., S. J. Harper, and J. Feehally. 1995. Galactosylation of N-and Olinked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 100: 470-474.
42. Moore, J. S., R. Kulhavy, M. Tomana, Z. Moldoveanu, H. Suzuki, R. Brown, S. Hall, M. Kilian, K. Poulsen, J. Mestecky, et al. 2007. Reactivities of Nacetylgalactosamine-specific lectins with human IgA1 proteins. Mol. Immunol. 44: 2598-2604.
43. Suzuki, H., Z. Moldoveanu, S. Hall, R. Brown, H. L. Vu, L. Novak, B. A. Julian, M. Tomana, R. J. Wyatt, J. C. Edberg, et al. 2008. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J. Clin. Invest. 118: 629-639.
44. Nordström, T., E. Movert, A. I. Olin, S. R. Ali, V. Nizet, A. Varki, and T. Areschoug. 2011. Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein. J. Biol. Chem. 286: 33981-33991.
45. Manea, M., A. Kristoffersson, R. Schneppenheim, M. A. Saleem, P. W. Mathieson, M. Mö rgelin, P. Björk, L. Holmberg, and D. Karpman. 2007. Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura. Br. J. Haematol. 138: 651-662.
46. Frémeaux-Bacchi, V., E. C. Miller, M. K. Liszewski, L. Strain, J. Blouin, A. L. Brown, N. Moghal, B. S. Kaplan, R. A. Weiss, K. Lhotta, et al. 2008. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112: 4948-4952.
47. Ståhl, A. L., F. Vaziri-Sani, S. Heinen, A. C. Kristoffersson, K. H. Gydell, R. Raafat, A. Gutierrez, O. Beringer, P. F. Zipfel, and D. Karpman. 2008. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood 111: 5307-5315.
48. Zoja, C., J. M. Wang, S. Bettoni, M. Sironi, D. Renzi, F. Chiaffarino, H. E. Abboud, J. Van Damme, A. Mantovani, G. Remuzzi, et al. 1991. Interleukin-1β and tumor necrosis factor-a induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am. J. Pathol. 138: 991-1003.
49. Wyatt, R. J., and B. A. Julian. 2013. IgA nephropathy. N. Engl. J. Med. 368: 2402-2414.
50. Colman, G., A. Tanna, A. Efstratiou, and E. T. Gaworzewska. 1993. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J. Med. Microbiol. 39: 165-178.
51. Berge, A., and L. Björck. 1995. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J. Biol. Chem. 270: 9862-9867.
52. Herwald, H., H. Cramer, M. Mörgelin, W. Russell, U. Sollenberg, A. Norrby-Teglund, H. Flodgaard, L. Lindbom, and L. Björck. 2004. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116: 367-379.
53. Tomana, M., K. Matousovic, B. A. Julian, J. Radl, K. Konecny, and J. Mestecky. 1997. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52: 509-516.
54. Tomana, M., J. Novak, B. A. Julian, K. Matousovic, K. Konecny, and J. Mestecky. 1999. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104: 73-81.
55. Allen, A. C., E. M. Bailey, J. Barratt, K. S. Buck, and J. Feehally. 1999. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J. Am. Soc. Nephrol. 10: 1763-1771.
56. Coletta, I., L. Soldo, N. Polentarutti, F. Mancini, A. Guglielmotti, M. Pinza, A. Mantovani, and C. Milanese. 2000. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex. Exp. Nephrol. 8: 37-43.
57. Timmerman, J. J., C. L. Verweij, D. J. van Gijlswijk-Janssen, F. J. van derWoude, L. A. van Es, and M. R. Daha. 1995. Cytokine-regulated production of the major histocompatibility complex class-III-encoded complement proteins factor B and C4 by human glomerular mesangial cells. Hum. Immunol. 43: 19-28.
58. Song, D., W. Zhou, S. H. Sheerin, and S. H. Sacks. 1998. Compartmental localization of complement component transcripts in the normal human kidney. Nephron 78: 15-22.
59. Abe, K., M. Miyazaki, T. Koji, A. Furusu, K. Shioshita, S. Tsukasaki, Y. Ozono, T. Harada, H. Sakai, and S. Kohno. 2001. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy. Nephron 87: 231-239.
60. Suzuki, H., K. Kiryluk, J. Novak, Z. Moldoveanu, A. B. Herr, M. B. Renfrow, R. J. Wyatt, F. Scolari, J. Mestecky, A. G. Gharavi, and B. A. Julian. 2011. The pathophysiology of IgA nephropathy. J. Am. Soc. Nephrol. 22: 1795-1803.
61. Tamouza, H., J. M. Chemouny, L. Raskova Kafkova, L. Berthelot, M. Flamant, M. Demion, L. Mesnard, E. Paubelle, F. Walker, B. A. Julian, et al. 2012. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Kidney Int. 82: 1284-1296.
62. Gao, Y. H., L. X. Xu, J. J. Zhang, Y. Zhang, M. H. Zhao, and H. Y. Wang. 2007. Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules. Clin. Exp. Immunol. 148: 507-514.
63. Lai, K. N., W. Y. To, P. K. Li, and J. C. Leung. 1996. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int. 49: 839-845.
64. McDonald, K. J., A. J. Cameron, J. M. Allen, and A. G. Jardine. 2002. Expression of Fc a/m receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem. Biophys. Res. Commun. 290: 438-442.
65. Moura, I. C., M. Arcos-Fajardo, C. Sadaka, V. Leroy, M. Benhamou, J. Novak, F. Vrtovsnik, E. Haddad, K. R. Chintalacharuvu, and R. C. Monteiro. 2004. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 15: 622-634.
66. Bisno, A. L., M. O. Brito, and C. M. Collins. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3: 191-200.
67. Areschoug, T., M. Stålhammar-Carlemalm, I. Karlsson, and G. Lindahl. 2002. Streptococcal b protein has separate binding sites for human factor H and IgAFc. J. Biol. Chem. 277: 12642-12648.